Maynard Um
-
-
-
-
-
-
-
Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 13c
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
-
-
-
-
-
-
-
Pliant Therapeutics (PLRX) PT Lowered to $1.50 at Citi
-
-
-
-
-
-
-
Pliant Therapeutics Inc. (PLRX) Announces Next Steps Following DSMB Recommendation on BEACON-IPF
-
-
-
-
-
-
-
Citi Downgrades Pliant Therapeutics (PLRX) to Neutral
-
-
-
-
-
-
-
Pliant Therapeutics (PLRX) Appoints Gary Palmer as SVP of Medical Affairs
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)
-
443,936 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

